
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (32): 4085-4090.DOI: 10.12114/j.issn.1007-9572.2022.0382
• Article·Epidemiologic Research • Previous Articles Next Articles
Received:2022-04-29
Revised:2022-08-01
Published:2022-11-15
Online:2022-08-18
Contact:
LIU Gang
About author:
通讯作者:
刘刚
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0382
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 占总死亡人数比例(%) | |
| 2014 | 46.79 | 77.22 | 1.26 | 2.57 | 25.34 | 44.40 | 1.94 | 3.57 | 75.33 | 127.76 | 77.20 |
| 2015 | 58.80 | 96.39 | 1.98 | 4.19 | 27.87 | 48.85 | 1.23 | 2.31 | 89.89 | 151.74 | 76.58 |
| 2016 | 52.71 | 89.16 | 3.38 | 6.40 | 24.87 | 41.88 | 2.78 | 5.11 | 83.73 | 142.55 | 79.35 |
| 2017 | 50.45 | 84.89 | 2.10 | 4.02 | 21.35 | 35.69 | 1.48 | 2.82 | 75.38 | 127.41 | 82.63 |
| 2018 | 50.51 | 87.20 | 2.15 | 3.95 | 21.84 | 37.27 | 1.93 | 3.55 | 76.43 | 131.98 | 82.01 |
| 2019 | 44.77 | 78.60 | 1.98 | 3.71 | 19.73 | 34.22 | 1.83 | 3.47 | 68.31 | 120.00 | 82.03 |
| 2020 | 47.38 | 82.16 | 2.07 | 4.01 | 21.34 | 37.67 | 1.49 | 2.90 | 72.28 | 126.74 | 81.81 |
| APC(%) | -1.90 | -0.90 | 3.80 | 2.20 | -4.70 | -4.60 | -1.30 | -0.60 | -2.70 | -2.00 | 1.20 |
| Z值 | -1.20 | -0.60 | 0.70 | 0.40 | -3.50 | -2.90 | -0.20 | -0.10 | -1.90 | -1.50 | 3.50 |
| P值 | 0.290 | 0.600 | 0.540 | 0.710 | 0.017 | 0.032 | 0.821 | 0.909 | 0.119 | 0.201 | 0.020 |
Table 1 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen permanent residents aged 30-69 from 2014 to 2020
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 占总死亡人数比例(%) | |
| 2014 | 46.79 | 77.22 | 1.26 | 2.57 | 25.34 | 44.40 | 1.94 | 3.57 | 75.33 | 127.76 | 77.20 |
| 2015 | 58.80 | 96.39 | 1.98 | 4.19 | 27.87 | 48.85 | 1.23 | 2.31 | 89.89 | 151.74 | 76.58 |
| 2016 | 52.71 | 89.16 | 3.38 | 6.40 | 24.87 | 41.88 | 2.78 | 5.11 | 83.73 | 142.55 | 79.35 |
| 2017 | 50.45 | 84.89 | 2.10 | 4.02 | 21.35 | 35.69 | 1.48 | 2.82 | 75.38 | 127.41 | 82.63 |
| 2018 | 50.51 | 87.20 | 2.15 | 3.95 | 21.84 | 37.27 | 1.93 | 3.55 | 76.43 | 131.98 | 82.01 |
| 2019 | 44.77 | 78.60 | 1.98 | 3.71 | 19.73 | 34.22 | 1.83 | 3.47 | 68.31 | 120.00 | 82.03 |
| 2020 | 47.38 | 82.16 | 2.07 | 4.01 | 21.34 | 37.67 | 1.49 | 2.90 | 72.28 | 126.74 | 81.81 |
| APC(%) | -1.90 | -0.90 | 3.80 | 2.20 | -4.70 | -4.60 | -1.30 | -0.60 | -2.70 | -2.00 | 1.20 |
| Z值 | -1.20 | -0.60 | 0.70 | 0.40 | -3.50 | -2.90 | -0.20 | -0.10 | -1.90 | -1.50 | 3.50 |
| P值 | 0.290 | 0.600 | 0.540 | 0.710 | 0.017 | 0.032 | 0.821 | 0.909 | 0.119 | 0.201 | 0.020 |
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
|---|---|---|---|---|---|---|---|---|
| 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
| 2014 | 54.28 | 95.52 | 0.44 | 0.85 | 35.41 | 63.23 | 2.55 | 5.00 |
| 2015 | 73.44 | 73.44 | 0.93 | 1.80 | 42.69 | 76.46 | 1.77 | 3.57 |
| 2016 | 59.06 | 59.06 | 4.62 | 8.85 | 37.32 | 63.48 | 3.85 | 7.19 |
| 2017 | 56.48 | 101.69 | 2.34 | 4.51 | 32.27 | 53.50 | 2.26 | 4.43 |
| 2018 | 57.16 | 103.73 | 3.00 | 5.51 | 31.75 | 54.28 | 3.17 | 5.90 |
| 2019 | 50.18 | 93.51 | 2.69 | 4.97 | 29.09 | 50.42 | 2.69 | 5.41 |
| 2020 | 57.23 | 106.03 | 3.44 | 6.71 | 35.29 | 62.34 | 2.46 | 5.08 |
| APC(%) | -2.20 | 5.00 | 32.40 | 31.90 | -3.30 | -3.60 | 1.90 | 2.50 |
| Z值 | -1.00 | 1.20 | 2.40 | 2.40 | -1.60 | -1.50 | 0.40 | 0.60 |
| P值 | 0.350 | 0.270 | 0.060 | 0.070 | 0.171 | 0.187 | 0.720 | 0.606 |
Table 2 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen male permanent residents aged 30-69 from 2014 to 2020
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
|---|---|---|---|---|---|---|---|---|
| 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
| 2014 | 54.28 | 95.52 | 0.44 | 0.85 | 35.41 | 63.23 | 2.55 | 5.00 |
| 2015 | 73.44 | 73.44 | 0.93 | 1.80 | 42.69 | 76.46 | 1.77 | 3.57 |
| 2016 | 59.06 | 59.06 | 4.62 | 8.85 | 37.32 | 63.48 | 3.85 | 7.19 |
| 2017 | 56.48 | 101.69 | 2.34 | 4.51 | 32.27 | 53.50 | 2.26 | 4.43 |
| 2018 | 57.16 | 103.73 | 3.00 | 5.51 | 31.75 | 54.28 | 3.17 | 5.90 |
| 2019 | 50.18 | 93.51 | 2.69 | 4.97 | 29.09 | 50.42 | 2.69 | 5.41 |
| 2020 | 57.23 | 106.03 | 3.44 | 6.71 | 35.29 | 62.34 | 2.46 | 5.08 |
| APC(%) | -2.20 | 5.00 | 32.40 | 31.90 | -3.30 | -3.60 | 1.90 | 2.50 |
| Z值 | -1.00 | 1.20 | 2.40 | 2.40 | -1.60 | -1.50 | 0.40 | 0.60 |
| P值 | 0.350 | 0.270 | 0.060 | 0.070 | 0.171 | 0.187 | 0.720 | 0.606 |
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
|---|---|---|---|---|---|---|---|---|
| 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
| 2014 | 38.82 | 44.45 | 2.12 | 4.21 | 14.63 | 25.25 | 1.30 | 2.23 |
| 2015 | 43.20 | 65.76 | 3.10 | 6.42 | 12.07 | 20.56 | 0.66 | 1.07 |
| 2016 | 45.95 | 72.24 | 2.05 | 3.89 | 11.59 | 19.70 | 1.64 | 3.08 |
| 2017 | 44.02 | 69.05 | 1.85 | 3.46 | 9.71 | 17.16 | 0.65 | 1.21 |
| 2018 | 43.42 | 70.85 | 1.24 | 2.34 | 11.28 | 19.74 | 0.62 | 0.05 |
| 2019 | 39.01 | 64.26 | 1.23 | 2.42 | 9.75 | 17.40 | 0.90 | 1.55 |
| 2020 | 38.38 | 61.94 | 0.82 | 1.68 | 8.60 | 15.64 | 0.60 | 1.02 |
| APC(%) | -1.00 | 3.40 | -17.00 | -17.00 | -7.10 | -6.10 | -9.10 | -18.50 |
| Z值 | -0.70 | 1.10 | -4.80 | -4.70 | -4.70 | -4.10 | -1.30 | -0.80 |
| P值 | 0.490 | 0.330 | 0.010 | 0.006 | 0.005 | 0.010 | 0.240 | 0.477 |
Table 3 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen female permanent residents aged 30-69 from 2014 to 2020
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
|---|---|---|---|---|---|---|---|---|
| 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
| 2014 | 38.82 | 44.45 | 2.12 | 4.21 | 14.63 | 25.25 | 1.30 | 2.23 |
| 2015 | 43.20 | 65.76 | 3.10 | 6.42 | 12.07 | 20.56 | 0.66 | 1.07 |
| 2016 | 45.95 | 72.24 | 2.05 | 3.89 | 11.59 | 19.70 | 1.64 | 3.08 |
| 2017 | 44.02 | 69.05 | 1.85 | 3.46 | 9.71 | 17.16 | 0.65 | 1.21 |
| 2018 | 43.42 | 70.85 | 1.24 | 2.34 | 11.28 | 19.74 | 0.62 | 0.05 |
| 2019 | 39.01 | 64.26 | 1.23 | 2.42 | 9.75 | 17.40 | 0.90 | 1.55 |
| 2020 | 38.38 | 61.94 | 0.82 | 1.68 | 8.60 | 15.64 | 0.60 | 1.02 |
| APC(%) | -1.00 | 3.40 | -17.00 | -17.00 | -7.10 | -6.10 | -9.10 | -18.50 |
| Z值 | -0.70 | 1.10 | -4.80 | -4.70 | -4.70 | -4.10 | -1.30 | -0.80 |
| P值 | 0.490 | 0.330 | 0.010 | 0.006 | 0.005 | 0.010 | 0.240 | 0.477 |
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | |
| 2014 | 818 | 6.50 | 22 | 0.26 | 443 | 3.89 | 34 | 0.31 | 1 317 | 10.73 |
| 2015 | 1 097 | 7.80 | 37 | 0.43 | 520 | 4.29 | 23 | 0.23 | 1 677 | 12.45 |
| 2016 | 1 062 | 7.56 | 68 | 0.59 | 501 | 3.67 | 56 | 0.46 | 1 687 | 12.00 |
| 2017 | 1 127 | 7.21 | 47 | 0.37 | 477 | 3.12 | 33 | 0.28 | 1 684 | 10.77 |
| 2018 | 1 175 | 7.49 | 50 | 0.33 | 508 | 3.20 | 45 | 0.35 | 1 778 | 11.15 |
| 2019 | 1 128 | 6.74 | 50 | 0.33 | 497 | 2.96 | 46 | 0.33 | 1 721 | 10.17 |
| 2020 | 1 212 | 6.82 | 53 | 0.37 | 546 | 3.19 | 38 | 0.30 | 1 849 | 10.47 |
| APC(%) | -0.60 | 0.10 | -5.10 | 1.40 | -1.90 | |||||
| Z值 | -0.40 | 0.00 | -3.40 | 0.30 | -1.60 | |||||
| P值 | 0.697 | 0.991 | 0.019 | 0.772 | 0.171 | |||||
Table 4 Yearly probability of premature death from four major noncommunicable diseases and temporal trends among Shenzhen permanent residents aged 30-69 from 2014 to 2020
| 时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | |
| 2014 | 818 | 6.50 | 22 | 0.26 | 443 | 3.89 | 34 | 0.31 | 1 317 | 10.73 |
| 2015 | 1 097 | 7.80 | 37 | 0.43 | 520 | 4.29 | 23 | 0.23 | 1 677 | 12.45 |
| 2016 | 1 062 | 7.56 | 68 | 0.59 | 501 | 3.67 | 56 | 0.46 | 1 687 | 12.00 |
| 2017 | 1 127 | 7.21 | 47 | 0.37 | 477 | 3.12 | 33 | 0.28 | 1 684 | 10.77 |
| 2018 | 1 175 | 7.49 | 50 | 0.33 | 508 | 3.20 | 45 | 0.35 | 1 778 | 11.15 |
| 2019 | 1 128 | 6.74 | 50 | 0.33 | 497 | 2.96 | 46 | 0.33 | 1 721 | 10.17 |
| 2020 | 1 212 | 6.82 | 53 | 0.37 | 546 | 3.19 | 38 | 0.30 | 1 849 | 10.47 |
| APC(%) | -0.60 | 0.10 | -5.10 | 1.40 | -1.90 | |||||
| Z值 | -0.40 | 0.00 | -3.40 | 0.30 | -1.60 | |||||
| P值 | 0.697 | 0.991 | 0.019 | 0.772 | 0.171 | |||||
| 时间(年) | 男性 | 女性 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | |
| 2014 | 8.30 | 0.06 | 5.56 | 0.46 | 13.94 | 4.76 | 0.44 | 2.22 | 0.18 | 7.50 |
| 2015 | 10.60 | 0.14 | 6.69 | 0.36 | 17.09 | 5.05 | 0.69 | 1.87 | 0.09 | 7.59 |
| 2016 | 9.35 | 0.81 | 5.54 | 0.71 | 15.16 | 5.86 | 0.38 | 1.78 | 0.23 | 8.13 |
| 2017 | 8.87 | 0.40 | 4.66 | 0.45 | 13.64 | 5.65 | 0.32 | 1.57 | 0.12 | 7.58 |
| 2018 | 9.11 | 0.45 | 4.63 | 0.55 | 13.94 | 5.92 | 0.21 | 1.77 | 0.15 | 7.95 |
| 2019 | 8.29 | 0.45 | 4.27 | 0.52 | 12.78 | 5.28 | 0.21 | 1.63 | 0.15 | 7.19 |
| 2020 | 9.08 | 0.61 | 5.18 | 0.52 | 14.37 | 4.93 | 0.17 | 1.45 | 0.11 | 6.59 |
| APC(%) | -0.90 | 38.00 | -4.50 | 3.20 | -2.00 | 0.70 | -18.70 | -5.40 | -3.50 | -1.80 |
| Z值 | -0.50 | 2.40 | -2.00 | 0.80 | -1.20 | 0.40 | -4.80 | -4.10 | -0.60 | -1.60 |
| P值 | 0.618 | 0.060 | 0.107 | 0.472 | 0.277 | 0.695 | 0.005 | 0.010 | 0.575 | 0.170 |
Table 5 Sex-based analysis of yearly probability of premature death from four major noncommunicable diseases and temporal trends among Shenzhen permanent residents aged 30-69 from 2014 to 2020
| 时间(年) | 男性 | 女性 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | |
| 2014 | 8.30 | 0.06 | 5.56 | 0.46 | 13.94 | 4.76 | 0.44 | 2.22 | 0.18 | 7.50 |
| 2015 | 10.60 | 0.14 | 6.69 | 0.36 | 17.09 | 5.05 | 0.69 | 1.87 | 0.09 | 7.59 |
| 2016 | 9.35 | 0.81 | 5.54 | 0.71 | 15.16 | 5.86 | 0.38 | 1.78 | 0.23 | 8.13 |
| 2017 | 8.87 | 0.40 | 4.66 | 0.45 | 13.64 | 5.65 | 0.32 | 1.57 | 0.12 | 7.58 |
| 2018 | 9.11 | 0.45 | 4.63 | 0.55 | 13.94 | 5.92 | 0.21 | 1.77 | 0.15 | 7.95 |
| 2019 | 8.29 | 0.45 | 4.27 | 0.52 | 12.78 | 5.28 | 0.21 | 1.63 | 0.15 | 7.19 |
| 2020 | 9.08 | 0.61 | 5.18 | 0.52 | 14.37 | 4.93 | 0.17 | 1.45 | 0.11 | 6.59 |
| APC(%) | -0.90 | 38.00 | -4.50 | 3.20 | -2.00 | 0.70 | -18.70 | -5.40 | -3.50 | -1.80 |
| Z值 | -0.50 | 2.40 | -2.00 | 0.80 | -1.20 | 0.40 | -4.80 | -4.10 | -0.60 | -1.60 |
| P值 | 0.618 | 0.060 | 0.107 | 0.472 | 0.277 | 0.695 | 0.005 | 0.010 | 0.575 | 0.170 |
| [1] |
|
| [2] |
健康中国行动推进委员会. 健康中国行动(2019—2030年)[EB/OL]. [2022-06-26].
|
| [3] |
深圳市政协.健康深圳行动计划(2017-2020年)[EB/OL]. [2022-06-26].
|
| [4] |
王玲,陈伟文,张彩娟,等. 2015—2019年深圳市坪山区重要慢性病早死概率和去死因期望寿命分析[J]. 职业与健康,2021,37(9):1223-1227. DOI:10.13329/j.cnki.zyyjk.2021.0309.
|
| [5] |
|
| [6] |
|
| [7] |
徐继英,李新建,姚海宏,等. 上海市成年人慢性病相关危险因素行为特征研究[J]. 中华预防医学杂志,2013,47(9):821-825. DOI:10.3760/cma.j.issn.0253-9624.2013.09.011.
|
| [8] |
靳雅男,杨艺,谢帆,等. 2012—2016年宁夏心脑血管疾病死亡状况分析[J]. 中国慢性病预防与控制,2019,27(11):806-808,813. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.11.002.
|
| [9] |
雷智,张燕,刘霞,等. 四川省泸州市2017年心脑血管疾病死亡特征及疾病负担分析[J]. 现代预防医学,2019,46(18):3373-3376.
|
| [10] |
陈亦晨,陈华,周弋,等. 2002—2020年上海市浦东新区居民主要慢性病早死概率研究[J]. 中国全科医学,2022,25(9):1098-1104. DOI:10.12114/j.issn.1007-9572.2021.02.074.
|
| [11] |
杨梨丽,林启,王玉超,等. 2009—2018年舟山市4类主要慢性病早死概率及"健康中国2030"目标分析[J]. 中国慢性病预防与控制,2021,29(2):140-143. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.02.014.
|
| [12] |
刘倩云,钟定威,马敏杰,等. 2015—2019年中山市城区居民主要慢性病早死概率变化分析[J]. 中国公共卫生管理,2021,37(6):803-806. DOI:10.19568/j.cnki.23-1318.2021.06.0025.
|
| [13] |
吕丽娜,陈楠. 2010—2017年天津市河东区主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2020,28(1):74-77. DOI:10.16386/j.cjpccd.issn.1004-6194.2020.01.019.
|
| [14] |
陈娜,邓静,雷群建,等. 2011—2019年重庆市长寿区4类主要慢性病早死概率及变化趋势[J]. 保健医学研究与实践,2021,18(5):30-34.
|
| [15] |
陈培培,俞浩,娄培安,等. 2015—2019年徐州市主要慢性病过早死亡情况及变化趋势[J]. 中国慢性病预防与控制,2022,30(1):77-80. DOI:10.16386/j.cjpccd.issn.1004-6194.2022.01.019.
|
| [16] |
国务院办公厅. 国务院办公厅关于印发中国防治慢性病中长期规划(2017—2025年)的通知[EB/OL]. [2022-03-17].
|
| [17] |
丁贤彬,唐文革,焦艳,等. 2010—2016年重庆市4种主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2017,25(9):641-645. DOI:10.16386/j.cjpccd.issn.1004-6194.2017.09.001.
|
| [18] |
孙晓凯,刘付东,梁季,等. 2008—2017年盐城市主要慢性病死亡情况及其变化趋势分析[J]. 中国慢性病预防与控制,2019,27(4):314-317. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.04.019.
|
| [19] |
刘辉,丛革新,贾鑫. 2009—2018年天津市河北区主要慢性病过早死亡情况及其趋势分析[J]. 中国慢性病预防与控制,2021,29(8):639-642. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.08.019.
|
| [1] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [2] | PAN Ziyun, YIN Hao, LIN Zhirou, MAO Jingyi, HUANG Yan, LUO Yanhua, XIAO Jiafu, HU Yin. From Mechanism to Therapy: Diabetic Autonomic Neuropathy [J]. Chinese General Practice, 2026, 29(21): 2982-2988. |
| [3] | YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao. Research and Application of Digital Health Technologies in Multimorbidity Management [J]. Chinese General Practice, 2026, 29(21): 2933-2937. |
| [4] | WANG Yang, ZHAO Shiting, CHEN Yingying, SUN Zilin, QIU Shanhu. Key Points of Exercise Intervention and Implementation for People with Complications of Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(21): 2989-2994. |
| [5] | LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039. |
| [6] | GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao. Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(20): 2854-2859. |
| [7] | CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807. |
| [8] | ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital [J]. Chinese General Practice, 2026, 29(19): 2614-2620. |
| [9] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [10] | CHEN Qiulong, CHEN Jia, FANG Jing, DAI Wei, YANG Qing. Application Status and Research Progress of Observer-reported Outcome [J]. Chinese General Practice, 2026, 29(18): 2561-2570. |
| [11] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [12] | LI Menglin, DING Fang, QIAN Yu, PU Dong, DU Qianqian, GUAN Tianhang, HE Yilin. Study on Glycemic Control Status and Influencing Factors among Community Diabetic Patients [J]. Chinese General Practice, 2026, 29(17): 2334-2339. |
| [13] | FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258. |
| [14] | WANG Rui, LUO Dan, YANG Cuicui, WENG Xinyi, WANG Yubing, XU Jingjing. Complex Network Analysis of Resilience in Adolescents with Type 1 Diabetes Mellitus Based on Multi-sourced Stigma [J]. Chinese General Practice, 2026, 29(16): 2264-2272. |
| [15] | JIN Chunhua, ZHANG Yawen, LI Lianxi. Association between Serum Bilirubin Within the Normal Range and Carotid Plaques in Elderly Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(15): 1986-1991. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||